Quarterly report pursuant to Section 13 or 15(d)

OPERATING SEGMENTS - Narrative (Details)

v3.23.2
OPERATING SEGMENTS - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jul. 01, 2022
Jun. 30, 2023
Jul. 01, 2022
Segment Reporting Information [Line Items]        
Business Exit Costs $ 35   $ 35  
Tax litigation expense 6   6  
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 2 $ 35 84 $ 30
Equity Method Investment, Other than Temporary Impairment   96   96
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee       (24)
Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   1    
Productivity and Reinvestment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives 24 19 51 29
BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction (3) (13) (7) (8)
Europe, Middle East & Africa        
Segment Reporting Information [Line Items]        
Equity Method Investment, Other than Temporary Impairment   96   96
North America        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives 8   26  
Business Exit Costs 5 11 11 23
North America | Operating Income (Loss)        
Segment Reporting Information [Line Items]        
Business Exit Costs       22
North America | Productivity and Reinvestment        
Segment Reporting Information [Line Items]        
Refinement of previously established accruals (1)   (1)  
North America | BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction   2   21
Asia Pacific        
Segment Reporting Information [Line Items]        
Business Exit Costs 35   35  
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees     140  
Bottling investments        
Segment Reporting Information [Line Items]        
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 2 35 (56) 30
Corporate        
Segment Reporting Information [Line Items]        
Tax litigation expense 6   6  
Debt and Equity Securities, Gain (Loss) 127 (267) 240 (371)
Gain (Loss) on Disposition of Business     439  
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee       (24)
Corporate | Productivity and Reinvestment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives 25 19 52 29
Corporate | fairlife        
Segment Reporting Information [Line Items]        
Contingent Consideration Liability 1,262 917 1,324 939
Corporate | BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction $ (3) $ (15) $ (7) $ (29)